CompanyDrug

Eli Lilly Delays Donanemab Action Date as FDA Calls for Advisory Committee Review

Policy / Regulatory

China Cracks Down on Medical Insurance Fraud with New Guidelines and Increased Prosecutions

CompanyDrug

FDA Approves Wegovy for Cardiovascular Risk Reduction in Obese Patients, First of Its Kind

CompanyDrug

Amgen Reports Positive Results for Otezla in Pediatric Psoriasis Trial

Company

Merck’s 2023 Annual Report: A Mixed Bag Amid Global Challenges

Company

GSK Reports US Adult Non-Flu Vaccination Rates Recover Post-Pandemic

CompanyDrug

BMS’s Opdivo Secures FDA Approval for First-Line Urothelial Carcinoma Treatment

CompanyDrug

BeiGene’s Brukinsa Receives FDA Approval for Relapsed or Refractory Follicular Lymphoma

CompanyDrug

Visen Pharmaceuticals’ TransCon hGH Accepted for Review by China’s NMPA

CompanyDeals

Shandong Luoxin Pharmaceutical Partners with Xbiome to Access Microbiome Transplantation Technology

CompanyDrug

Shanghai Fosun Pharma Gets NMPA Green Light for Universal NK Cell Therapy GCK-01 Clinical Study

CompanyDrug

Novo Nordisk’s Anti-Obesity Drug Wegovy Eyed for China Launch in 2024